Interaction Between IV Cocaine and Quetiapine

National Institute on Drug Abuse (NIDA)1 site in 1 country12 target enrollmentOctober 2003

ConditionsCocaine-Related Disorders

DrugsQuetiapine

Overview

Phase: Phase 1
Intervention: Not specified
Conditions: Cocaine-Related Disorders
Sponsor: National Institute on Drug Abuse (NIDA)
Enrollment: 12
Locations: 1
Primary Endpoint: pharmacokinetic assessment
Last Updated: 9 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The purpose of this study is to assess the safety of intravenous (IV) cocaine in subjects taking quetiapine at 3 dosage levels.

Detailed Description

A placebo-controlled, double-blind, inpatient assessment of interaction between intravenous cocaine and quetiapine (seroquel) in cocaine-experienced subjects. To assess the safety of IV cocaine in subjects taking quetiapine at 3 dosage levels.

Registry

clinicaltrials.gov

Start Date

October 2003

End Date

TBD

Last Updated

9 years ago

Study Type

Interventional

Sex

All

Investigators

Sponsor

National Institute on Drug Abuse (NIDA)

Eligibility Criteria

Inclusion Criteria

•Includes but is not limited to: non-treatment seeking individuals. Must meet DSM-IV criteria for cocaine abuse or dependence. Must be able to verbalize understanding of consent and provide written informed consent and verbalize willingness to complete study procedures. Site will provide further details.